Current Value of Holding

$23.2 Million

Shares

388 Thousand

% of Portfolio

0.02%

Average Buy Price

$85.6

Avg closing price
Price range

46 Ken Griffin Biomarin Pharmaceutical - Registered Shares Trades

Ken Griffin acquired 291 Thousand Biomarin Pharmaceutical - Registered Shares shares worth $17.4 Million. That's 0.02% of their equity portfolio (904th largest holding). The first Biomarin Pharmaceutical - Registered Shares trade was made in Q2 2013. Since then Ken Griffin bought shares 56 more times and sold shares on 55 occasions. The investor's estimated purchase price is $25.8 Million, resulting in a loss of 32%.

Avg closing price
Price range
Sold 67.8% shares (-817 Thousand shares) Q4 2024
Avg closing price $66.95
Price range $61.93 - $70.53
Increased shares by 115.9% (+647 Thousand shares) Q3 2024
Avg closing price $83.67
Price range $69.02 - $93.84
Sold 71.8% shares (-1.42 Million shares) Q2 2024
Avg closing price $83.25
Price range $74.43 - $92.22
Increased shares by 456.6% (+1.62 Million shares) Q1 2024
Avg closing price $89.52
Price range $83.81 - $99.00
Increased shares by 150.8% (+213 Thousand shares) Q4 2023
Avg closing price $88.47
Price range $76.22 - $98.51
Sold 70.7% shares (-341 Thousand shares) Q3 2023
Avg closing price $88.98
Price range $85.07 - $94.48
Increased shares by 290.3% (+359 Thousand shares) Q2 2023
Avg closing price $94.11
Price range $86.68 - $100.30
Sold 5.3% shares (-6.93 Thousand shares) Q1 2023
Avg closing price $103.67
Price range $87.74 - $117.27
Sold 87.0% shares (-872 Thousand shares) Q4 2022
Avg closing price $93.88
Price range $80.93 - $108.63
Sold 13.1% shares (-151 Thousand shares) Q3 2022
Avg closing price $89.04
Price range $82.16 - $96.94
Sold 44.8% shares (-937 Thousand shares) Q2 2022
Avg closing price $79.62
Price range $71.48 - $86.85
Increased shares by 53.9% (+732 Thousand shares) Q1 2022
Avg closing price $83.67
Price range $74.28 - $92.69
Increased shares by 2667.5% (+1.31 Million shares) Q4 2021
Avg closing price $82.51
Price range $71.72 - $91.47
Sold 94.9% shares (-911 Thousand shares) Q3 2021
Avg closing price $78.90
Price range $74.77 - $85.47
Sold 41.2% shares (-674 Thousand shares) Q2 2021
Avg closing price $79.27
Price range $75.51 - $84.79
Sold 34.1% shares (-844 Thousand shares) Q1 2021
Avg closing price $81.69
Price range $74.73 - $90.69
Increased shares by 871.6% (+2.22 Million shares) Q3 2020
Avg closing price $101.18
Price range $71.87 - $131.03
Sold 1.7% shares (-4.36 Thousand shares) Q2 2020
Avg closing price $99.39
Price range $79.55 - $124.22
Sold 87.3% shares (-1.78 Million shares) Q1 2020
Avg closing price $86.16
Price range $71.37 - $96.85
Increased shares by 16.1% (+283 Thousand shares) Q4 2019
Avg closing price $75.53
Price range $64.27 - $86.37

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!